+
+
7114 J. Am. Chem. Soc., Vol. 118, No. 30, 1996
Ohshima et al.
excess was determined by HPLC analysis (DAICEL CHIRALPAK AD,
hexane-2-propanol, 90:10, 1.0 mL/min, retention time: 15 min (+),
19 min (-)).
(br-s, 0.5 H), 2.29-2.19 (m, 2 H), 2.19-2.15 (br-s, 0.5 H), 1.74-1.64
(m, 1 H), 1.53-1.39 (m, 1 H), 1.19 (s, 1.5 H), 1.14 (s, 1.5 H), 1.11 (s,
4.5 H), 1.10 (s, 4.5 H); 13C-NMR (CDCl3) δ 203.56, 203.34 (s), 168.48,
168.37 (s), 157.52, 157.34 (s), 141.22, 141.08 (d), 135.53 (d, 4 C),
135.53, 132.35, 132.31 (s, 2 C), 129.97 (d, 2 C), 129.74, 129.38 (d),
127.84 (d, 4 C), 106.09, 106.02 (t), 69.92, 69.88 (t), 60.29, 59.91 (d),
57.20, 56.82 (s), 57.07, 56.28 (d), 54.74, 54.07 (d), 52.24, 52.11 (q),
38.35 (t), 33.19 (t), 27.64 (q), 26.63 (q, 3 C), 19.16 (s); MS m/z (relative
intensity) 445 (M+ - tBu,2), 385 (1), 313 (15), 133 (100). Anal. Calcd
for C31H38O4Si: C, 74.06; H, 7.62. Found: C, 73.78; H, 7.66. The
enantiomeric excess was determined by its conversion to methyl
((1S,4R,5R)-4-hydroxy-5-methyl-8-methylene-R-oxobicyclo[3.3.0]oct-
2-en-2-yl)acetate. See ref 18.
(1S,4S,5S)-4-(1-(Methoxycarbonyl)-2-oxopropyl)-1-methyl-6-meth-
ylenebicyclo[3.3.0]oct-2-ene (6d): IR (neat) 2952, 1746, 1716, 1160
cm-1; 1H-NMR (CDCl3) δ 5.53 (s, 1 H), 5.52 (dd, J ) 5.5, 2.2 Hz, 0.5
H), 5.46 (dd, J ) 5.5, 2.2 Hz, 0.5 H), 4.88-4.85 (m, 2 H), 3.77 (s, 1.5
H), 3.73 (s, 1.5 H), 3.41 (d, J ) 6.5 Hz, 0.5 H), 3.38 (d, J ) 6.0 Hz,
0.5 H), 3.27-3.23 (m, 1 H), 2.30-2.28 (m, 1 H), 2.27 (s, 1.5 H), 2.24
(s, 1.5 H), 2.25-2.21 (m, 2 H), 1.73-1.68 (m, 1 H), 1.58-1.42 (m, 1
H), 1.22 (s, 1.5 H), 1.20 (s, 1.5 H); 13C-NMR (CDCl3) δ 202.07 (s),
169.07, 169.02 (s), 157.48, 157.32 (s), 141.44, 141.19 (d), 129.49,
129.11 (d), 106.02, 105.95 (t), 66.43, 66.17 (d), 57.27, 57.18 (s), 56.62,
56.34 (d), 54.92, 54.63 (d), 52.29, 52.22 (q), 38.24 (t), 33.14 (t), 29.62,
29.35 (q), 27.6 (q); MS m/z (relative intensity) 248 (M+, 0.5), 205 (36),
189 (20), 173 (16), 145 (22), 132 (100); HR-MS (M+ - Ac) calcd for
C13H17O2 205.1229, found 205.1224; The enantiomeric excess was
determined by its conversion to methyl ((1S,4R,5R)-4-hydroxy-5-
(1S,4S,5S)-4-(Dibenzoylmethyl)-1-methyl-6-methylenebicyclo-
[3.3.0]oct-2-ene (6h): [R]25D +69.3 (c 1.01, CHCl3) (80% ee); IR (neat)
1
2949, 1698, 1596, 1448 cm-1; H-NMR (CDCl3) δ 8.02-7.97 (m, 4
H), 7.59-7.38 (m, 6 H), 5.54-5.47 (m, 2 H), 5.23 (d, J ) 10.6 Hz, 1
H) 4.90-4.87 (br-s, 1 H), 4.85-4.82 (br-s, 1 H), 3.77 (br-d, J ) 10.6
Hz, 1 H), 2.36-2.33 (br-s, 1 H), 2.30-2.14 (m, 2 H), 1.76-1.67 (m,
1 H), 1.54-1.40 (m, 1 H), 1.31 (s, 3 H); 13C-NMR (CDCl3) δ 195.06
(s), 194.57 (s), 157.50 (s), 140.99 (d), 136.95 (s), 136.89 (s), 133.46
(d, 2 C), 130.75 (d), 128.95 (d, 4 C), 128.84 (d, 4 C), 106.51 (t), 64.62
(d), 57.34 (d), 57.00 (d), 56.84 (s), 38.21 (t), 33.23 (t), 27.85 (q); MS
m/z (relative intensity) 356 (M+, 0.2), 279 (0.3), 251 (63), 132 (50),
105 (100: HR-MS (M+ - PhCO) calcd for C18H19O 251.1436, found
251.1440. The enantiomeric excess was determined by HPLC analysis
(DAICEL CHIRALPAK OD+OD, hexane-2-propanol, 99.5:0.5, 1.0
mL/min, retention time: 45 min (-), 50 min (+)).
methyl-8-methylene-R-oxobicyclo[3.3.0]oct-2-en-2-yl)acetate: [R]24
D
-101 (c 0.40, CHCl3) (83% ee); IR (neat) 3418, 2956, 1738, 1681,
1152 cm-1; 1H-NMR (CDCl3) δ 6.96-6.93 (br-s, 1 H), 5.10-5.07 (br-
s, 1 H), 4.96-4.91 (br-s, 1 H), 4.79-4.75 (br-s, 1 H), 3.89 (s, 3 H),
3.59-3.55 (br-s, 1 H), 2.43-2.34 (m, 2 H), 2.30-2.15 (br-s, 1 H),
1.89-1.78 (m, 1 H), 1.64-1.43 (m, 1 H), 1.16 (s, 3 H); 13C-NMR
(CDCl3) δ 183.29 (s), 162.64 (s), 150.66 (s), 150.24 (d), 142.17 (s),
109.45 (t), 83.27 (d), 59.43 (d), 55.58 (s), 52.74 (q), 37.47 (t), 33.17
(t), 20.13 (q); MS m/z (relative intensity) 236 (M+, 18), 205 (18), 177
(60), 149 (78), 94 (100); HR-MS (M+) calcd for C13H16O4 236.1048,
found 236.1055. The enantiomeric excess was determined by HPLC
analysis (DAICEL CHIRALPAK AS, hexane-2-propanol, 90:10, 1.0
mL/min, retention time: 10 min (+), 13 min (-)). See ref 18.
(1S,4S,5S)-4-(3-Chloro-1-(methoxycarbonyl)-2-oxopropyl)-1-methyl-
6-methylenebicyclo[3.3.0]oct-2-ene (6e). A mixture of 6e and 24 was
(1S,4S,5S)-4-(3-((tert-Butyldiphenylsilyl)oxy)-1-(ethoxycarbonyl)-
propyl)-1-methyl-6-methylenebicyclo[3.3.0]oct-2-ene (26). A solu-
tion of 6b (280.7 mg, 0.488 mmol), LiCl (41.4 mg, 0.977 mmol), and
H2O (8.8 µL, 0.488 mmol) in DMSO (0.81 mL) was refluxed with
stirring for 6 h. After being cooled, the reaction mixture was diluted
with H2O, extracted with Et2O, dried (Na2SO4), and concentrated. The
residue was purified by silica gel column chromatography (EtOAc-
hexane, 1:50) to give 26 (205.1 mg, 84%) as a colorless oil: IR (neat)
1
obtained: IR (neat) 1673, 1443, 1343, 1213 cm-1; H-NMR (CDCl3)
δ 5.58-5.40 (m, 2 H), 4.91-4.85 (m, 2 H), 4.28-4.23 (m, 2 H), 3.78
(s, 1.5 H), 3.74 (s, 1.5 H), 3.66 (d, J ) 10.3 Hz, 1 H), 3.30 (d, J )
10.3 Hz, 1 H), 2.39-2.35 (br-s, 1 H), 2.28-2.20 (m, 2 H), 1.75-1.66
(m, 1 H), 1.54-1.42 (m, 1 H), 1.23 (s, 1.5 H), 1.21 (s, 1.5 H); MS m/z
(relative intensity) 284 (M+ (37Cl), 0.2), 284 (M+ (35Cl), 0.3), 267 (4),
239 (3), 205 (42), 132 (100). The enantiomeric excess was determined
by its conversion to 6d.
1
2954, 1731, 1428, 1173, 1112, 702 cm-1; H-NMR (CDCl3) δ 7.69-
7.63 (m, 4 H), 7.46-7.34 (m, 6 H), 5.58 (dd, J ) 5.6, 2.3 Hz, 0.4 H),
5.51-5.47 (m, 1 H), 5.41 (dd, J ) 5.6, 2.3 Hz, 0.6 H), 4.81-4.78
(br-s, 1 H), 4.76-4.72 (br-s, 0.4 H), 4.71-4.69 (br-s, 0.6 H), 4.20-
4.00 (m, 2 H), 3.76-3.58 (m, 2 H), 2.81-2.74 (m, 1 H), 2.66-2.55
(m, 1 H), 2.42-2.37 (br-s, 1 H), 2.35-2.15 (m, 2 H), 2.02-1.73 (m,
2 H), 1.73-1.64 (m, 1 H), 1.54-1.41 (m, 1 H), 1.22 (t, J ) 7.1 Hz,
1.8 H), 1.21 (t, J ) 7.1 Hz, 1.2 H), 1.20 (s, 1.2 H), 1.19 (s, 1.8 H),
1.05 (s, 9 H); 13C-NMR (CDCl3) δ 175.11, 174.99 (s), 158.54, 158.51
(s), 140.41, 140.16 (d), 135.54 (d, 4 C), 133.82, 133.76 (s, 2 C), 130.05,
129.94 (d), 129.56 (d, 2 C), 127.60 (d, 4 C), 104.94, 104.55 (t), 62.01
(t), 60.11 (t), 58.56, 58.26 (d) 57.27, 57.05 (s), 56.77, 56.19 (d), 48.23,
47.26 (d), 38.83, 38.73 (t), 33.43, 33.30 (t), 33.05, 32.98 (t), 27.64 (q),
26.81 (q, 3 C), 19.19 (s), 14.27 (q); MS m/z (relative intensity) 502
(M+, 0.1), 445 (84), 227 (34), 133 (100); HR-MS (M+) calcd for
C32H42O3Si 502.2903, found 502.2919.
(1S,4S,5S)-4-(3-((tert-Butyldiphenylsilyl)oxy)-1-(hydroxymethyl)-
propyl)-1-methyl-6-methylenebicyclo[3.3.0]oct-2-ene (27). To a
stirred solution of 26 (60.7 mg, 0.121 mmol) in CH2Cl2 (1.2 mL) was
added a solution of DIBALH (0.98 M, in hexane, 0.37 mL, 0.38 mmol)
at -78 °C. After gradually being warmed to 0 °C and 15 min further
of stirring, the reaction mixture was quenched by the addition of
saturated aqueous NH4Cl solution at the same temperature and excess
Et2O was added. The mixture was stirred at rt for 15 h, extracted with
Et2O, dried (Na2SO4), and concentrated. The residue was purified by
silica gel column chromatography (EtOAc-hexane, 1:10) to give 27
(53.3 mg, 96%) as a colorless oil: IR (neat) 3410, 2931, 1717, 1428,
1362, 701 cm-1; 1H-NMR (CDCl3) δ 7.71-7.66 (m, 4 H), 7.48-7.36
(m, 6 H), 5.54-5.49 (m, 1 H), 5.49-5.44 (m, 1 H), 4.78-4.75 (br-s,
1 H), 4.74-4.70 (br-s, 0.4 H), 4.70-4.66 (br-s, 0.6 H), 3.87-3.59 (m,
4 H), 2.94-2.84 (br-s, 0.4 H), 2.84-2.71 (br-s, 0.6 H), 2.64-2.55 (m,
1 H), 2.37-2.13 (m, 3 H), 1.82-1.53 (m, 4 H), 1.53-1.40 (m, 1 H),
1.18 (s, 1.2 H), 1.17 (s, 1.8 H), 1.07 (s, 9 H); 13C-NMR (CDCl3) δ
159.28, 159.07 (s), 139.71, 139.62 (d), 135.60 (d, 4 C), 133.24 (s, 2
C), 130.82, 130.64 (d), 129.76 (d, 2 C), 127.73 (d, 4 C), 104.15, 103.99
(t), 65.16, 64.82 (t), 63.18 (t), 58.11, 57.88 (d), 57.04, 57.00 (s), 56.89,
(1S,4S,5S)-4-[1,3-Bis(methoxycarbonyl)-2-oxopropyl]-1-methyl-
6-methylenebicyclo[3.3.0]oct-2-ene (6f):19 IR (neat) 2952, 1744, 1436,
1
1244, 1162 cm-1; H-NMR (CDCl3) δ 5.56-5.47 (m, 2 H), 5.22 (s,
0.1 H), 5.17 (s, 0.1 H), 4.95-4.75 (m, 2 H), 3.76, 3.75, 3.73, 3.72,
3.71 (s, 6 H), 3.65-3.51 (m, 2.4 H), 3.29-3.26 (m, 0.5 H), 3.25-3.22
(m, 0.5 H), 2.99 (d, J ) 10.6 Hz, 0.1 H), 2.93 (d, J ) 10.6 Hz, 0.1 H),
2.38-2.20 (m, 3 H), 1.76-1.65 (m, 1 H), 1.56-1.40 (m, 1 H), 1.21,
1.20, 1.19 (s, 3 H); 13C-NMR (CDCl3) δ 196.55, 196.44 (s), 168.52,
168.43 (s), 166.94, 166.81 (s), 157.39, 157.25 (s), 141.71 (d), 129.09,
128.90 (d), 106.27, 106.16 (t), 65.59, 65.37 (d), 57.34 (s), 56.59, 56.37
(d), 55.06, 54.66 (d), 52.53, 52.47, 52.36 (q, 2 C), 48.52, 48.20 (t),
38.30 (t), 33.19 (t), 27.60 (q); MS m/z (relative intensity) 306 (M+,
0.4), 205 (58), 132 (100). Anal. Calcd for C17H22O5: C, 66.65; H,
7.24. Found: C, 66.54; H, 7.54. The enantiomeric excess was
determined by its conversion to methyl ((1S,4R,5R)-4-hydroxy-5-
methyl-8-methylene-R-oxobicyclo[3.3.0]oct-2-en-2-yl)acetate. See ref
18.
(1S,4S,5S)-4-(3-((tert-Butyldiphenylsilyl)oxy)-1-(methoxycarbon-
yl)-2-oxopropyl)-1-methyl-6-methylenebicyclo[3.3.0]oct-2-ene (6g):
IR (neat) 2952, 1723, 1113, 758, 702 cm-1; 1H-NMR (CDCl3) δ 7.68-
7.62 (m, 4 H), 7.49-7.36 (m, 6 H), 5.56 (dd, J ) 5.6, 2.1 Hz, 0.5 H),
5.51 (dd, J ) 5.6, 1.5 Hz, 0.5 H), 5.45 (dd, J ) 5.5, 1.6 Hz, 0.5 H),
5.27 (dd, J ) 5.5, 2.2 Hz, 0.5 H), 4.96-4.92 (br-s, 0.5 H), 4.91-4.87
(br-s, 0.5 H), 4.87-4.83 (m, 1 H), 4.31 (d, J ) 12.5 Hz, 0.5 H), 4.29
(d, J ) 13.0 Hz, 0.5 H), 4.27 (d, J ) 12.5 Hz, 0.5 H), 4.24 (d, J )
13.0 Hz, 0.5 H), 3.78 (d, J ) 9.2 Hz, 0.5 H), 3.69 (d, J ) 10.3 Hz, 0.5
H), 3.68 (s, 1.5 H), 3.65 (s, 1.5 H), 3.33-3.23 (m, 1 H), 2.42-2.38
(18) Ohshima, T.; Sodeoka, M.; Shibasaki, M. Tetrahedron Lett. 1993,
34, 8509.
(19) 6f was obtained as an equilibrium mixture of the keto form and
2,3-enol form (ca. 8:2).